0      0

Session 5: Leadership Roundtable: A Look at the News; Facts or Fiction?

Sep 15, 2020 12:10pm ‐ Sep 15, 2020 1:30pm

Credits: None available.


Leaders from Sponsors, Sites, CROs, Advocacy Groups, and Technology Providers will take part in a roundtable focused on challenges and opportunities resulting from emerging trends (e.g. the impact of COVID-19 and continuity of trials) that impact patients and sites as the industry moves towards more “virtual” or “decentralized” clinical trials (i.e.: BYOD, Telemedicine, eCOA, eSource, eConsent, Home Nursing, UP Home Delivery, and New Players including Google, Apple, and Walmart.)


  • TJ Sharpe, Patient Engagement Program Manager, Medidata



  • Dr. Stephanie Abbott, PharmD, Research Director, Western Washington Medical Group
  • Jennifer Byrne, BSc, Founder, Board Chair, and CEO, Javara and Greater Gift
  • Grace Crawford, Global Head of Clinical Quality and Compliance, AstraZeneca
  • Betsy Fallen, RN, Consultant, BAFallen Consulting LLC
  • Sharon Hanlon, Head, Clinical Trial Engagement & Contract Management, BMS
  • Evonne Lackey, BA, CCRP, Director of Clinical Research, Swedish Cancer Institute
  • Andy Lee, SVP, Head Global Clinical TrialOperations, Merck. Treasurer, TransCelerate, TransCelerate Biopharma Inc.
  • Tim Rich, Executive Director, Innovation and Virtual Operations, PPD
  • Ana Santos Alejandro, Director, Corporate Quality Relationships, Syneos Health


Credits: None available.

You must be logged in and own this session in order to post comments.